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Understanding the regulatory networks underlying lineage differentiation and fate determination of human
bone marrow stromal cells (hBMSC) is a prerequisite for their therapeutic use. The goal of the current study
was to unravel the novel role of the low-density lipoprotein receptor-related protein 3 (LRP3) in regulating
the osteogenic and adipogenic differentiation of immortalized hBMSCs. Gene expression proﬁling revealed sig-
niﬁcantly higher LRP3 levels in the highly osteogenic hBMSC clone imCL1 than in the less osteogenic clone
imCL2, as well as a signiﬁcant upregulation of LRP3 during the osteogenic induction of the imCL1 clone. Data
from functional and gene expression assays demonstrated the role of LRP3 as a molecular switch promoting
hBMSC lineage differentiation into osteoblasts and inhibiting differentiation into adipocytes. Interestingly,
microRNA (miRNA) expression proﬁling identiﬁed miR-4739 as the most under-represented miRNA (−36.11
fold) in imCL1 compared to imCL2. The TargetScan prediction algorithm, combinedwith functional and biochem-
ical assays, identiﬁed LRP3mRNA as a novel target of miR-4739, with a single potential binding site formiR-4739
located in the LRP3 3′UTR. Regulation of LRP3 expression bymiR-4739was subsequently conﬁrmed by qRT-PCR,
western blotting, and luciferase assays. Over-expression of miR-4739 mimicked the effects of LRP3 knockdown
on promoting adipogenic and suppressing osteogenic differentiation of hBMSCs. Hence, we report for the ﬁrst
time a novel biological role for the LRP3/hsa-miR-4739 axis in balancing osteogenic and adipocytic differentiation
of hBMSCs. Our data support the potential utilization of miRNA-based therapies in regenerative medicine.
© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Throughout life, a homeostatic mechanism within the marrow cavi-
ty regulates fat and bone tissue formation. Both tissues originate from
the same bone marrow progenitor cells; these are known as skeletal
stem cells (SSCs), bone marrow-derived multipotent stromal cells, or
mesenchymal stem cells (Bianco and Robey, 2004; Caplan, 1991;
Friedenstein, 1976, 1968; Friedenstein et al., 1966; Owen and
Friedenstein, 1988). SSCs are multipotent stromal cells that can differ-
entiate into adipocytes, osteoblasts, or chondrocytes in response to var-
ious microenvironmental stimuli, including growth factors, cytokines,
and epigenetic regulators (Beresford et al., 1992; Gimble and Nuttall,
2004; Gimble et al., 1996). An imbalance between osteogenic and
adipogenic lineage commitment and differentiation has been implicat-
ed as a cause of age-related impairment of bone formation. Thus,
some therapeutic interventions have been proposed that aim to en-
hance bone mass by targeting SSCs and improving their functions
(Yokota et al., 2002, 2003).
The low-density lipoprotein receptor-related protein (LRP) family is
an evolutionarily conserved groupof cell-surface receptors that regulate
diverse biological functions in different organs, tissues, and cell types, in
mammals and species of other taxa (Strickland et al., 1994; Croy et al.,
2003). In addition to the function of LRPs as endocytic receptors that
mediate the uptake of lipoproteins, several studies have demonstrated
the involvement of these receptors inmany cellular processes, including
signal transduction, synaptic plasticity regulation, neuronal migration,
cholesterol control, and vitamin homeostasis (Goretzki and Mueller,
1998; Trommsdorff et al., 1999; Gotthardt et al., 2000; Garcia et al.,
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2001; Li et al., 2001a;Nykjaer andWillnow, 2002). LRP3 is an LRP family
member expressed in a wide range of human tissues, with the highest
expression observed in skeletal muscles and ovaries (Ishii et al., 1998).
It has been reported that LRP3 modulates the cellular uptake of β-
VLDL (Very Low Density Lipoprotein) (Ishii et al., 1998; Jeong et al.,
2010). In contrast to LRP5 that has been demonstrated to participate
in the canonical WNT pathway, bone formation, as well as in skeletal
homeostasis and diseases (Abdallah et al., 2015; Clément-Lacroix et
al., 2005; Haÿ et al., 2009; Kato et al., 2002; Williams and Insogna,
2009), the biological function of LRP3 has not been elucidated yet.
MicroRNAs (miRNAs) are a class of small, non-coding single-strand-
ed RNAs (18–24 nucleotides) thatmodulate protein expression by bind-
ing to one or more types of mRNAs, which results in either translation
repression or mRNA degradation (Ambros, 2004; Bartel, 2004; Pillai,
2005; Tétreault and De Guire, 2013). It has been reported that N
17.000mature miRNA sequences are currently present in over 140 spe-
cies, including plants, algae, viruses, and animals (Kozomara and
Grifﬁths-Jones, 2011). These small molecules participate in the regula-
tion of a variety of biological processes such as organ development, as
well as cell proliferation, differentiation, motility, and apoptosis
(Huang et al., 2010; Jia et al., 2014; Tétreault and De Guire, 2013).
Since 2001, several studies have demonstrated an important role for a
number ofmiRNAs in bone biology, as theywere found to regulate oste-
oblastic and chondrogenic differentiation, as well as bone formation
(i.e., ossiﬁcation) (Dong et al., 2012; Laine et al., 2012a; Papaioannou
et al., 2014; Pi et al., 2015; Eskildsen et al., 2011). Similarly, adipogenic
differentiation has also been reported to be regulated by several
miRNAs. This suggests a possible use of targetingmiRNAs as therapeutic
agents for enhancing bone formation by regulating the balance between
the osteogenic and adipogenic differentiation processes (Skårn et al.,
2012; Laine et al., 2012b; Hamam et al., 2014).
We recently described two immortalized human bonemarrow stro-
mal cell (hBMSCs) clones, imCL1 and imCL2, that were established
through the over-expression of human telomerase reverse transcriptase
(hTERT) in bone marrow-derived hBMSCs, with imCL1 exhibiting en-
hanced bone and fat formation compared to imCL2 (Elsafadi et al.,
2016) In the current study, we established a novel regulatory network
consisting of hsa-miR-4739 and LRP3 that balances the osteoblastic
and adipocytic differentiation of hBMSCs.
2. Materials & methods
2.1. Cell culture
We employed a hBMSC-TERT cell line created from primary normal
human bonemarrow BMSCs by over-expressing the human telomerase
reverse transcriptase gene (hTERT) (Abdallah et al., 2005; Al-Nbaheen et
al., 2013). These cells have been extensively characterized and exhibit a
cellular and molecular phenotype similar to that of primary hBMSCs
(Al-Nbaheen et al., 2013). In the experiments described in this study,
we employed two sub-clones derived from these hBMSCs, called
imCL1 and imCL2, that exhibit enhanced or reduced osteogenic,
adipogenic, and chondrogenic differentiation potential, respectively
(Elsafadi et al., 2016). Human imCL1 and imCL2 cellswere both cultured
in Dulbecco's modiﬁed Eagle's medium (DMEM) supplemented with
4500 mg/L D-glucose, 4 mM L-glutamine, 110 mg/L sodium pyruvate,
10% fetal bovine serum (FBS), 1× penicillin-streptomycin (Pen-Strep),
and non-essential amino acids. All culture reagents were purchased
from Gibco (Thermo Fisher Scientiﬁc, Waltham, MA, USA).
2.2. siRNA-mediated transfection of hBMSCs
Cells in logarithmic growth phase were reverse-transfected with
25 nM of the Ambion Silencer Select Pre-designed LRP3-siRNA (Assay
ID: s8284, Cat. No. 4390824; Thermo Fisher Scientiﬁc) or the Ambion Si-
lencer Select Negative Control No. 2 siRNA (Cat. No. 4390846; Thermo
Fisher Scientiﬁc) using the Invitrogen Lipofectamine RNAiMAX Reagent
(Thermo Fisher Scientiﬁc) plus serum-free Gibco Opti-MEM I medium
(ThermoFisher Scientiﬁc) as per themanufacturer's recommendedpro-
tocol. On the third day post-transfection, cells were induced to osteo-
genic or adipogenic differentiation and then incubated for an
additional week.
2.3. Alamar Blue cell viability/proliferation assay
Cell viabilitywas evaluated using the Alamar Blue assay according to
the manufacturer's recommendations (Cat. No. BUF012B; AbD Serotec,
Raleigh, NC, USA). In brief, 10 μL of Alamar Blue substrate was added
to cultured cells in 96-well plates, followed by incubation in the dark
at 37 °C for 1 h. Readingswere subsequently takenusing a Synergy IImi-
croplate reader (BioTek Instruments, Winooski, VT, USA) set at ﬂuores-
cent mode (excitation wavelength, 530 nm; emission wavelength,
590 nm).
2.4. Western blotting
Whole cell lysates were prepared as previously described (Elsafadi
et al., 2016). Total proteins were analyzed by blotting with anti-LRP3
(Cat. No. ab112581, rabbit anti-human LRP3 antibody, 83 kDa, dilution
1:250; Abcam, Cambridge, UK), and anti-β-actin (Cat. No. A3854, dilu-
tion 1:10,000; Sigma-Aldrich, St. Louis, MO, USA). Non-immune immu-
noglobulin of the same isotype was used as a negative control.
Reactivity was detected with horseradish peroxidase-conjugated sec-
ondary antibodies (Santa-Cruz Biotechnology, Dallas, TX, USA) andClar-
ity Western ECL substrate (Bio\\Rad, Hercules, CA, USA). Produced
chemiluminescence was measured using a C-Digit Blot Scanner (LI-
COR Biosciences, Lincoln, NE, USA).
2.5. In vitro osteoblast differentiation
Cells were grown in 6-well plates, standard DMEM, and at a density
of 0.3 × 106 cells/mL.When cells reached 70–80% conﬂuence, theywere
cultured in DMEM supplemented with an osteogenic induction supple-
ments containing 10% FBS, 1% Pen-Strep, 50 μg/mL L-ascorbic acid
(Wako Chemicals, Neuss, Germany), 10 mM β-glycerophosphate
(Sigma-Aldrich), 10 nM calcitriol (1α,25-dihydroxyvitamin D3;
Sigma), and 10 nM dexamethasone (Sigma-Aldrich). The medium was
replaced three times per week.
2.6. In vitro adipocyte differentiation
Cells were grown in standard DMEM, 6-well plates at 20,000 cells/-
cm2. At 90–100% conﬂuence, cells were cultured in DMEM supplement-
edwith an adipogenic inductionmixture containing 10% FBS, 10% Horse
Serum (Sigma-Aldrich), 1% Pen-Strep, 100 nM dexamethasone,
0.45 mM isobutyl methylxanthine (Sigma-Aldrich)(Hildebrand et al.,
1994), 3 μg/mL insulin (Sigma-Aldrich), and 1 μM rosiglitazone (Serra
and Chang, 2003). Medium was replaced 3 times per week.
2.7. Cytochemical staining
2.7.1. Alizarin Red S staining of mineralized matrix
Cell layers were washed with PBS and then ﬁxed with 4% parafor-
maldehyde (Sigma-Aldrich) for 15 min at room temperature. After re-
moving the ﬁxative, each cell layer was rinsed with distilled water and
then stained with 2% Alizarin Red S (Alizarin Red S Staining Kit; Cat.
No. 0223; Sciencell Research Laboratories, Carlsbad, CA, USA) for 20–
30 min at room temperature. Excess dye was washed away with
water. For quantiﬁcation, the bound dye was ﬁrst eluted by incubating
each stained cell layerwith 800 μL of acetic acid for 30min at room tem-
perature as previously described (Gregory et al., 2004), and then
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measured using an Epoch spectrophotometer (BioTek Instruments) at
405 nm.
2.7.2. OsteoImage mineralization assay
Themineralizedmatrixwas quantiﬁed using the OsteoImageMiner-
alization Assay Kit (Cat. No. PA-1503; Lonza, Allendale, NJ, USA). After
removal of the culture medium, cells were washed once with PBS and
then ﬁxed with 70% cold ethanol for 20 min. The appropriate amount,
as recommended by the manufacturer, of diluted staining reagent was
added, and the plates were incubated in the dark for 30 min at room
temperature. Afterwards, cells were washed, and the bound reagent
was quantiﬁed using a ﬂuorescent plate reader (excitation wavelength,
530nm; emission wavelength, 590nm).
2.7.3. Oil Red-O staining of lipid droplets
Mature adipocytesﬁlledwith cytoplasmic lipid dropletswere visual-
ized by staining with Oil Red-O. After washing with PBS, the cells were
ﬁxed in 4% formaldehyde for 10 min at room temperature, rinsed once
with 3% isopropanol, and stained for 1 h at room temperature using ﬁl-
teredOil Red-O staining solution (prepared bydissolving 0.5 gOil Red-O
powder in 60% isopropanol). Quantiﬁcation of the formed mature adi-
pocytes was performed by adding 100% isopropanol to each well to
elute the bound Oil Red-O stain and then measuring color intensity
using the BioTek Epoch spectrophotometer at 510 nm.
2.7.4. Nile Red ﬂuorescence determination and quantiﬁcation of mature
adipocytes
The stock solution of Nile Red (1mg/mL in DMSO)was prepared and
stored protected from light at−20 °C. Cultured undifferentiated and
differentiated cells were ﬁxed with 4% paraformaldehyde for 15 min
and then washed once with PBS. Afterwards, a 5 μg/mL dye solution in
PBS was added directly to the cells. After 10min of incubation at room
temperature, the ﬂuorescence signal was measured using a
SpectraMax/M5 ﬂuorescence spectrophotometer plate reader (Molecu-
lar Devices, Sunnyvale, CA, USA) set at bottom well-scan mode. Nine
readings were measured per well (excitation wavelength, 485 nm;
emission wavelength, 572 nm).
2.8. Quantitative real time PCR (qRT-PCR)
Total RNA was extracted using the Ambion PureLink RNA Mini Kit
(Cat. No. 12183018A; Thermo Fisher Scientiﬁc) as recommended by
the manufacturer, and quantiﬁed by a Nanodrop 2000 spectrophotom-
eter (Thermo Fisher Scientiﬁc). Complementary DNA (cDNA) was syn-
thesized from 1 μg RNA using the Applied Biosystems High Capacity
cDNA Reverse Transcription Kit (Thermo Fisher Scientiﬁc) in a
Multigene thermocycler (Labnet International, Edison, NJ, USA) accord-
ing to the manufacturer's instructions. Relative mRNA levels were de-
termined from cDNA by real-time PCR using the Applied Biosystems
Real Time PCR Detection System (Thermo Fisher Scientiﬁc), with the
Fig. 1. Expression of LRP3 during in vitro differentiation of imCL1 and imCL2 cells. (A) Venn diagram depicting the overlap between the group of differentially over-represented genes in
imCL1 and imCL2 cells, and the group of over-represented genes during the osteogenic differentiation (day 7) of imCL1 cells (B) Quantitative TaqMan Real-Time PCR for determining LRP3
mRNA levels in imCL1 and imCL2 cells. (C) QRT-PCR quantiﬁcation of LRP3 transcript at different time points [D0 (non-induced), D1, D3, D5, and D7] during osteogenic and adipogenic
differentiation of imCL1 cells. (D) QRT-PCR quantiﬁcation of LRP3 mRNA on day 3 post-transfection with LRP3-speciﬁc or scrambled control siRNA. Data are presented as fold change
of mRNA levels in LRP3-siRNA-transfected cells compared to those of cells transfected with scrambled siRNA. (E) QRT-PCR quantiﬁcation of LRP3mRNA in imCL1 cells transfected with
LRP3-siRNA or scrambled-control siRNA, at baseline and on day 3 post osteogenic induction. GAPDHmRNA levels were used as a normalizer. Data are presented as mean ± SD, n = 3.
Each experiment was performed at least two times; *P b 0.05; **P b 0.01, ***P b 0.005. (F) Representative western blots for LRP3 protein in scrambled-siRNA- or LRP3-siRNA-
transfected cells. β-Actin was used as a loading control. (G) Alamar Blue determination of cell viability performed on scrambled-siRNA- or LRP3-siRNA-transfected cells at the
indicated time points. No differences in cell viability between the two groups were observed.
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Applied Biosystems Power SYBR Green PCR Kit (Thermo Fisher Scientif-
ic) or the Applied Biosystems TaqMan Universal Master Mix II without
Uracil-N-Glycosylase (UNG) (Thermo Fisher Scientiﬁc), according to
the manufacturer's instructions. Following normalization to the refer-
ence gene GAPDH, quantiﬁcation of gene expression was carried out
using a comparative CT method where ΔCT is the difference between
the CT values of the target and the reference gene. Primers used in the
current study are listed in Supplementary Tables 4 and 5.
2.9. DNA microarray global gene expression proﬁling
Total RNAwas extractedwith theAmbion PureLinkRNAMini Kit fol-
lowing themanufacturer's instructions. Afterwards, 150 ng of total RNA
was labeled and then hybridized to the Agilent Human SurePrint G3
Human GE 8 × 60 k microarray chip (Agilent Technologies, Santa
Clara, CA, USA). All microarray experiments were conducted at the Mi-
croarray Core Facility of the Stem Cell Unit, Anatomy Department, Col-
lege of Medicine, King Saud University. Normalization and data
analyses were performed using the GeneSpring GX software (Agilent
Technologies). Pathway analysis was conducted using the Single Exper-
iment Pathway analysis feature of GeneSpring 12.0 (Agilent Technolo-
gies). A fold change (FC) of two with P b 0.02 was chosen as cutoff.
2.10. miRNA expression proﬁling
MicroRNA expression proﬁling of imCL1 and imCL2 cells was con-
ducted. First, total RNA was extracted with the Total RNA Puriﬁcation
Kit (Cat. No. 37500; Norgen, Thorold, ON, Canada), and 200 ng was
used for RNA labeling and hybridization onto the Human SurePrint G3
8 × 60 k v16 miRNA microarray chip (Agilent Technologies) according
to the manufacturer's protocol. Data were subsequently normalized
and analyzed using GeneSpring GX. A FC of two with P b 0.01 was
used as cutoff to determine the differentially expressed miRNAs be-
tween imCL1 and imCL2 (Elsafadi et al., 2016). Target prediction was
conducted based on the TargetScan database, using the corresponding
built-in feature of GeneSpring GX.
2.11. miRNA transfection
The reverse transfection approach was used as described before
(Alajez et al., 2011) for the miRNA mimic Ambion Negative Control
No. 1 (Cat. No. 4464058; Thermo Fisher Scientiﬁc) and the Ambion
hsa-miR-4739 (Cat. No. 4464066; Thermo Fisher Scientiﬁc). Brieﬂy,
miRs were diluted in 50 μL of Gibco Opti-MEM (Cat. No. 11058-021;
Thermo Fisher Scientiﬁc) to a ﬁnal concentration of 60 nM, whereas
1.5 μL of Invitrogen Lipofectamine 2000 (Part No: 52758; Thermo Fisher
Scientiﬁc) was diluted in 50 μL Opti-MEM. The diluted miR-mimics,
siRNA, and Lipofectamine 2000 were mixed and incubated at ambient
temperature for 20 min. The transfection mixture was then added to
24-well cell culture plates (100 μL per well), followed by the addition
of 400 μL transfectionmedium (routine culturemediumwithout antibi-
otics) containing 50,000 cells to each well. Every experiment included
the appropriate controls, was performed in triplicate, and was repeated
at least two times. Plates were incubated for the indicated time points,
and proliferation or growth inhibition was assessed using the Alamar
Blue assay, as described in 2.3.
Fig. 2. LRP3 silencing inhibits osteogenesis and promotes adipogenesis in imCL1 cells. (A) imCL1 cells were differentiated into osteoblasts by treatment with an osteogenic mixture for
5 days. Mineralized calcium deposition was determined by Alizarin Red S staining. Scanned images of stained wells are displayed. Representative images were taken at 10×
magniﬁcation. (B) Quantiﬁcation of mineralized calcium deposition under different treatment conditions: non-induced scrambled-siRNA-transfected cells, osteogenic-induced
scrambled-siRNA-transfected cells, and osteogenic-induced LRP3-siRNA-transfected cells. (C) QRT-PCR for osteogenic gene markers (ALPL, OSP, ITGA10, CDh11, and DKK2) under
different treatment conditions: non-induced scrambled-siRNA transfected cells, osteogenic-induced scrambled-siRNA-transfected cells, and osteogenic-induced LRP3-siRNA-
transfected cells. (D) imCL1 cells transfected with scrambled or LRP3 siRNA were induced with an adipogenic mixture for 5 days and stained using Oil Red-O for accumulated oil
droplets. (E) Quantiﬁcation of oil content using Nile Red staining after different treatments: non-induced scrambled-siRNA-transfected, adipogenic-induced scrambled-siRNA-
transfected, and adipogenic-induced LRP3-siRNA-transfected cells. (F) Total RNA was extracted and qRT-PCR was performed for the adipogenic marker genes ADIPOQ, AP2, LPL, and
PPARG. Results are representative of at least two independent experiments. Data are presented as mean ± SD, n = 3; *P b 0.05; **P b 0.01, ***P b 0.005.
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2.12. Luciferase assay
To determine whether hsa-miR-4739 directly interacts with the 3′
untranslated region (3′-UTR) of the LRP3 mRNA, HEK-293 cells were
co-transfected with 30 nM of either miR-CNT (control) or miR-4739
mimics, and 50 ng/μL of either the miTarget negative control clone
(Cat. No. CmiT000001-MT05; GeneCopoeia, Rockville, MD, USA) or the
LRP3 miTarget miRNA 3′-UTR Clone (Cat. No. HmiT1010872-MT05;
GeneCopoeia). Transfection experiments were conducted using
Invitrogen Lipofectamine 2000. At 72 h post transfection, Gaussia lucif-
erase (Gluc) activity was measured using the Secrete-Pair Lumines-
cence Assay Kit (GeneCopoeia). Secreted alkaline phosphatase (SEAP)
activity was used for normalization as we previously described
(Vishnubalaji et al., 2016).
2.13. Statistical analysis
All results were presented as mean ± SD (standard deviation) of at
least two independent experiments. Each experiment was performed
in triplicate. Student's t-test was used for evaluating differences be-
tween groups. P b 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Expression of LRP3 during immortalized hBMSC differentiation
We recently established two immortalized hBMSC clones, namely
imCL1 and imCL2, exhibiting remarkable differences in their osteogenic
and adipocytic differentiation potentials. Speciﬁcally, imCL1 displays
enhanced osteogenic and adipocytic differentiation compared to
imCL2 (Elsafadi et al., 2016). Gene expression proﬁling identiﬁed 462
genes that were over-represented in the imCL1 compared to the
imCL2 line (Supplementary Table 1). When CL1 cells were subjected
to osteogenic differentiation, 396 genes were over-represented (Sup-
plementary Table 1). Interestingly, 120 of these 396 genes also belonged
to the group of 462 genes whose expression was higher in imCL1 com-
pared to imCL2 cells (Fig. 1A, Supplementary Table 1). LRP3 was the
most prominent among these 120 genes (FC = 6.6, P b 0.05, imCL1 vs.
imCL2 cells, Fig. 1B). QRT-PCR analysis revealed a signiﬁcant increase
in LRP3 mRNA levels during in vitro osteogenic differentiation, while
no signiﬁcant changes were observed during adipocytic differentiation
(Fig. 1C). In follow-up experiments, we carried out siRNA-mediated si-
lencing of LRP3 in the presence or absence of osteogenic induction me-
dium. QRT-PCR conﬁrmed a signiﬁcant down-regulation of LRP3mRNA
Fig. 3. Gene expression proﬁling of LRP3-depleted cells. (A) Hierarchical clustering of parental scrambled cells and LRP3-depleted cells based on the levels of differentially expressed
mRNAs. Each row represents one replica, and each column represents a transcript. The expression level of each gene in a single sample is depicted according to the color scale. (B)
QRT-PCR validation of the microarray data for selected genes; n = 3, *P b 005, ***P b 0001. Scrambled cells were used as a control. (C) Pie chart illustrating the distribution of the top
pathway designations for the deregulated genes in LRP3-siRNA transfected cells. (D) Venn diagram illustrating the overlap between the differentially over-represented genes during
the osteogenic differentiation of scrambled imCL1 cells and the under-represented genes after LRP3 knockdown. (E) Venn diagram illustrating the overlap between the differentially
over-represented genes during the adipogenic differentiation of scrambled imCL1 cells and the over-represented genes after LRP3 knockdown.
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expression (Fig. 1D–E), while western blot analysis conﬁrmed the sup-
pression of LRP3 expression at the protein level (Fig. 1F). LRP3-deﬁcient
in imCL1 did not exhibit changes in cell proliferation, as determined by
the Alamar Blue viability and proliferation assay (Fig. 1G).
3.2. LRP3-deﬁcient cells showed impaired osteoblastic and enhanced
adipocytic differentiation
To investigate the potential role of LRP3 in regulating imCL1 differ-
entiation, imCL1 cells were transfected with LRP3 siRNA and then ex-
posed to osteogenic induction medium. LRP3-siRNA-transfected
imCL1 cells exhibited impaired osteoblast differentiation. This was
demonstrated by both a signiﬁcant reduction inmineralizedmatrix for-
mation, as visualized by Alizarin Red staining (Fig. 2A–B). Furthermore,
there was decreased expression of osteoblastic markers TNAP (tissue
non-speciﬁc alkaline phosphatase), SPP1 (osteopontin), ITGA10
(integrin alpha-10), CDH11 (cadherin-11), and DKK2 (dickkopf-related
protein-2) (Fig. 2C). In contrast, LRP3-deﬁcient imCL1 cells exhibited
enhanced adipocytic differentiation, as shown by an increased number
of lipid-ﬁlled mature adipocytes, quantiﬁed by Nile Red staining (Fig.
2D–E) and over-represented expression of a panel of adipocytic
markers, namely AN (adiponectin), aP2 (adipocyte Protein 2), LPL
(Lipoprotein Lipase), and PPARG (Peroxisome Proliferator Activated Re-
ceptor Gamma) (Fig. 2F).
3.3. Molecular signature of LRP3-deﬁcient imCL1 cells
To determine the molecular mechanism mediating the functions of
LRP3 in hBMSCs, we performed global gene expression proﬁling of
imCL1 transfected with LRP3 siRNA or scrambled control siRNA. Hierar-
chical clustering revealed that control cells and LRP3-deﬁcient cells
clustered separately (Fig. 3A). We found that 1709 genes were over-
represented and 1022 genes under-represented in LRP3-deﬁcient cells
compared to control cells (FC ≥ 2.0, P b 0.02). To conﬁrm themicroarray
data,we performedqRT-PCR for selected genes of these two groups that
are known to be involved in cell differentiation and the TGFβ pathway.
Results showed a good concordance between microarray and qRT-PCR
data (Fig. 3B). Bioinformatics analysis revealed that LRP3-deﬁcient
cells exhibited enrichment in genes belonging to several intracellular
signaling pathways, including pathways related to the regulation of
the actin cytoskeleton, focal adhesions, endochondral ossiﬁcation, adi-
pogenesis, the TGFβ signaling pathway, and the MAPK cascade (Fig.
3C). We subsequently identiﬁed the genes that might be associated
with the impaired osteogenic and augmented adipocytic differentiation
of LRP3-deﬁcient imCL1 cells. Data revealed 93 genes shared by the
Fig. 4.Direct regulation of LRP3 bymiR-4739. (A) Schematic presentation showing the alignment of themature hsa-miR-4793 sequence and the putative binding site in the 3′-UTR region
of the LRP3mRNA. The TargetScan databasewas used. The exact positionswhere the LRP33′-UTR and themiR-4739 seed region interact are indicated. (B\\C)Over-expression of hsa-miR-
4739was associatedwith a signiﬁcant decrease in LRP3mRNA (B) and protein (C); ***P b 0.005. LRP3-siRNA-transfected cells were used as a positive control. (D) LRP3 3′-UTR or a control
vector were co-transfected with a miR control (30nM) or miR-4739 (30nM) mimics in HEK-293 cells. Gluc luciferase activity was measured 72h following transfection, while luciferase
activity from SEAP was used for data normalization. Data are presented as mean ± S.D., n = 6; **P b 0.005. (E) Alamar Blue quantiﬁcation of cell viability in the ﬁrst four days post-
transfection of imCL1 cells with hsa-miR-4739, LRP3-siRNA, or pre-miR-control.
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group of genes that were under-represented in LRP3-deﬁcient cells and
the group of genes that were over-represented during the osteoblastic
differentiation of control hBMSCs (Fig. 3D, Supplementary Table 2).
Among these 93 genes, TWIST1, TBXAS1, CALCA, PDE4D, ASPN, TGIF1,
PIM1, NFIA, C5AR1, CSGALNACT1, and HOXDA have been previously
shown to play a role during osteogenesis and bone development
(Chen et al., 2015; Driller et al., 2007; Fromental-Ramain et al., 1996;
Geneviève et al., 2008; Huebner et al., 2008; Kalbasi Anaraki et al.,
2014; Kim et al., 2010a; Quarto et al., 2015; Sato et al., 2011; Ueda et
al., 2016; Wakabayashi et al., 2002). On the other hand, 104 genes
were over-represented in LPR3-deﬁcient imCL1 cells as well as in con-
trol cells differentiated into adipocytes. Among those, APOE, ANGPTL4,
CES1, CBS, DUSP1, BMP6, ATF3, SAA1, BTG2, GDF15, CPE, LRP1B, and
ADHFE1 have been previously reported to play a role during adipogene-
sis (Chiba et al., 2003; Ferguson et al., 2015; Jang and Jung, 2014; Jernås
et al., 2009; Kim et al., 2007, 2016; Masson et al., 2009; Min et al., 2005;
Sharma et al., 2014; Tsai et al., 2015;Wang et al., 2015b, 2010; Yanagitai
et al., 2012) (Fig. 3E and Supplementary Table 3).
3.4. miR-4739 mediates its biological effects through targeting LRP3
We subsequently investigated the mechanism underlying LRP3 up-
regulation in imCL1 cells. MicroRNA expression proﬁling revealed that
hsa-miR-4739 is one of the most down-regulated miRNAs in imCL1
compared to imCL2 cells (FC = −36.11 fold; Table 1), suggesting a
plausible role for this miRNA in regulating hBMSC differentiation. In
silico predictions conducted with the TargetScan algorithm revealed a
single potential binding site for hsa-miR-4739, located in the 3′-UTR
of the LRP3 mRNA (Fig. 4A). The role of hsa-miR-4739 in regulating
LRP3 expression was conﬁrmed by qRT-PCR and western blotting,
which showed suppression of LRP3 mRNA and protein expression, re-
spectively, in hsa-miR-4739 transfected imCL1 cells (Fig. 4B–C). Cells
transfected with siRNA against LRP3 were used as a positive control.
To conﬁrm that the LRP3 mRNA is indeed a direct target for hsa-miR-
4739, we performed a luciferase reporter assay. HEK-293 cells were
co-transfected with an LRP3 3′-UTR reporter clone in which the LRP3
3′-UTR was cloned downstream of the Gluc gene. The vector also
contained the SEAP gene as a transfection control. Results revealed a sig-
niﬁcant suppression (~30%) of luciferase activity produced by the LRP3
3′-UTR reporter clone in anhsa-miR-4739-dependentmanner (Fig. 4D).
No signiﬁcant difference was observed in cell viability or proliferation
between cells transfected with miR-control, hsa-miR-4739, or LRP3
siRNA during the four-day follow-up period (Fig. 4E).
3.5. 3.5. Identiﬁcation of miR-4739 as bona ﬁde regulator of hBMSCs
differentiation
To examine the biological role of hsa-miR-4739 in regulating osteo-
genic and adipocytic differentiation of hBMSCs, imCL1 cells were
transfected with eithermiR-Control or hsa-miR-4739 and subsequently
exposed to osteogenic and adipogenic induction medium. Hsa-miR-
4739-trasfected imCL1 exhibited a suppression of differentiation into
osteoblastic cells, as evidenced by reduced Alizarin Red S staining for
mineralized matrix formation, and conﬁrmed by the quantiﬁcation of
mineralized nodules as well as by the down-regulation of the expres-
sion of osteogenic markers (Fig. 5A–C). Moreover, cells overexpressing
hsa-miR-4739 exhibited enhanced formation of lipid-ﬁlled mature adi-
pocytes (Fig. 5D). Concordant with these data, a higher number of cells
were positive for Nile Red staining in imCL1 cultures transfected with
hsa-miR-4739 compared to control cultures (Fig. 5E). These ﬁndings
were conﬁrmed by an adipocyte-speciﬁc gene expression assay that re-
vealed over-representation of aP2 and PPARg2 (Fig. 5F). These effects of
hsa-miR-4739 on hBMSC differentiation were further conﬁrmed by
using primary human BMSCs, which provided similar results
Fig. 5. Over-expression of hsa-miR-4793 suppressed osteogenic differentiation and enhanced adipogenic differentiation of imCL1 cells. imCL1 cells were transfected with miR-CNT, miR-
4739, or LRP3-siRNA (as a positive control) and then subjected to osteoblastic or adipogenic differentiation induction for 7 days. (A)Mineralized calcium depositionwas determined using
Alizarin Red S staining for the different treatment groups. (B) Quantiﬁcation ofmineralized nodules using theOsteoImageMineralization Assay under different transfection conditions. (C)
QRT-PCR for osteogenic marker genes (ALPL, RUNX2, and OSP) in miR-CNT-, miR-4739-, or LRP3-siRNA-transfected cells. (D) Oil Red-O staining of accumulated oil droplets in induced
imCL1 cells under different treatment conditions. (E) Nile Red staining quantiﬁcation of oil content in miR-CNT-, miR-4739-, or LRP3-siRNA-transfected imCL1 cells after seven days of
adipogenic induction. (F) QRT-PCR quantiﬁcation of adipogenic markers (AP2 and PPARG) under different treatment conditions. Data are presented as mean ± SD, n = 3. Data are
representative of at least two independent experiments; *P b 0.05; **P b 0.01, ***P b 0.005.
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(Supplementary Fig. 1). These results suggest a role for hsa-miR-4739-
mediated LRP3 suppression in regulating both the osteoblastic and the
adipocytic differentiation of hBMSCs. In Fig. 6, we present a schematic
model illustrating the novel biological role for miR-4739 as an impor-
tant regulator of LRP3 activity, promoting inhibition of osteogenic dif-
ferentiation and enhancement of adipogenic differentiation of hBMSCs
through the regulation of several genes and pathways related to osteo-
genic and adipogenic differentiation.
4. Discussion
Identifying regulatory circuits that determine the reciprocal rela-
tionship between osteogenic and adipogenic differentiation is necessary
for deﬁning the fate of hSSCs/BMSCs and their clinical use in regenera-
tive medicine. In the current study, we established a novel role of
LRP3 in regulating the osteogenic and adipogenic differentiation of
hBMSCs. Moreover, our data identiﬁed hsa-miR-4739 as a molecular
switch regulating the balance between osteoblastic and adipocytic dif-
ferentiation of hBMSCs through the control of LRP3 expression.
It has been reported that the interactions of members of the LRP
family trigger a wide range of biological functions, such as endocytosis,
signal transduction, cellular communication, cholesterol control, and vi-
tamin homeostasis (Gotthardt et al., 2000; Li et al., 2001b, 2001a;
Nykjaer andWillnow, 2002). LRP5 has been implicated in the regulation
of bonemineral density aswell as in different types of bone-related dis-
eases through modulation of the Wnt signaling pathway (Haÿ et al.,
2009; Xu et al., 2014; Abdallah et al., 2015;Wolski et al., 2015). Howev-
er, the biological function of LRP3, which exhibits 9.98% homology with
LRP5 (as calculated by NCBI protein BLAST) had not yet been described,
although LRP3’s highest expression is found in skeletal muscles (Ishii et
al., 1998). In the current study, we employed a loss-of-function ap-
proach to demonstrate the ability of LRP to exert opposing effects on
hBMSC osteogenic (enhancement) and adipogenic (inhibition) differ-
entiation, without affecting cell proliferation. It is thus plausible that
LRP3 exerts its effects on hBMSCs by enhancing the osteogenic differen-
tiation or by shifting SSC commitment to the osteogenic lineage at the
expense of adipogenesis. This hypothesis is supported by microarray-
based gene expression data that revealed a number of dysregulated os-
teogenesis- and adipogenesis-related pathways in LRP3-depleted
imCL1 cells, such as regulation of actin cytoskeleton, TGFβ signaling, ad-
ipogenesis, endochondral ossiﬁcation, focal adhesion, andMAPK signal-
ing pathways.
Fig. 6. A proposed schematic model for the novel biological role of miR-4739 as an regulator of LRP3 gene. LRP3 gene inhibition lead to reduced osteogenic and enhancing adipogenic
differentiation of hBMSCs through the modulation of several genes and pathways related to osteogenic and adipogenic differentiation.
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Several studies have reported pivotal roles for some miRNAs in
hBMSC-lineage commitment and fate determination that are mediated
by their ability to modulate differentiation-regulating factors. For in-
stance, miR-210, miR-206, miR-133, miR-2861, and miR-138 have
been implicated in the regulation of osteogenic differentiation via mod-
ulation of the TGFB type I receptor, connexin 43, RUNX2,HDACs, and the
FAK, while miR-21, miR-375, miR-27a, and miR-320c have been in-
volved in the regulation of adipogenic differentiation through modula-
tion of TGFB1, ERK1/2, PPARG, and RUNX2 (Eskildsen et al., 2011;
Hamam et al., 2014; Hu et al., 2011; Inose et al., 2009; Kim et al.,
2010b, 2009; Li et al., 2008; Ling et al., 2011; Mizuno et al., 2009). To
identify the molecular mechanism regulating LRP3 expression in
hBMSCs, we performed miRNA expression proﬁling in the imCL1 and
imCL2 clones,which revealed some differentially expressedmiRNAs be-
tween the two clones. Interestingly, hsa-miR-4739, which we subse-
quently identiﬁed as a bone ﬁde regulator of LRP3 expression, was the
most under-represented miRNA in imCL1 compared to imCL2. Thus
far, only three studies have reported on hsa-miR-4739 functions, linking
it to unilineage hematopoietic stem cell differentiation and acute mye-
loid leukemia, β-catenin signaling pathway and gastric cancer, as well
as in the pathogenesis of negative anaplastic large cell lymphoma
(Cattaneo et al., 2015; Dong et al., 2015; Wang et al., 2015a). Hence,
our data extend the list of possible biological roles of hsa-miR-4739 by
demonstrating its ability to regulate LRP3-mediated osteogenic at the
expense of adipogenic differentiation of hBMSCs, which suggests that
it functions as a molecular switch during hSSC differentiation. It is plau-
sible that hsa-miR-4739 has additional gene targets besides LRP3 that
might also regulate hSSC/BMSC osteogenic and adipocytic differentia-
tion. In fact, investigation of the TargetScan database identiﬁed LRP4
as a potential target for hsa-miR-4739; however, the direct regulation
of LRP4 by hsa-miR-4739 remains to be proven. Therefore, we propose
the use of hsa-miR-4739 mimics or inhibitors to ﬁne-tune the commit-
ment of hBMSCs to the osteogenic or the adipogenic lineage, with po-
tential application in regenerative medicine.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2017.03.001.
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